About
Technology
Issues
FAQ
Links
Official Page
Subcutaneous versus intravenous administration of bortezomib in patients with relapsed multiple myeloma: a randomised, phase 3, non-inferiority study
Distribution of the number of citations over years.
site/software ©
exaly
; All materials licenced under
CC by-SA
.